Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1/2 5Phase 1 5Phase 3 4Phase 2/3 3Phase NA 1Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 7Glioma 6Brain Neoplasms 3Neuroblastoma 2Sarcoma 1Rhabdoid Tumor 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Medulloblastoma 1Gliosarcoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Desmoplastic Small Round Cell Tumor 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 7fludarabine 4Dasatinib 2zimberelimab 1pembrolizumab 1palbociclib 1olaparib 1fluorodopa F 18 1Vincristine 1Vemurafenib 1Topotecan 1Temozolomide 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Magnetic Resonance Spectroscopy 1Influenza Vaccines 1Fluoxetine 1Fluorodeoxyglucose F18 1Everolimus 1Etoposide 1Doxorubicin 1Decitabine 1Cholestanetriol 26-Monooxygenase 1CVAD protocol 1Busulfan 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recurrence × Temozolomide × Clear all
NCT05634707 2025-09-22

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Duke University

Phase EARLY_PHASE1 Active not recruiting
10 enrolled
CNS

Brain Neoplasms, Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡